No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Namenda (memantine) is a drug used to treat moderate to severe Alzheimer's disease and other forms of dementia. It is a centrally acting NMDA receptor antagonist, which works by blocking the action of glutamate, a neurotransmitter that is thought to be involved in the development of Alzheimer's disease. Namenda is the only drug approved by the FDA for the treatment of moderate to severe Alzheimer's disease. It is also used off-label to treat other forms of dementia, such as vascular dementia and Lewy body dementia.
Namenda is part of a larger market of Central Nervous System (CNS) drugs, which includes drugs used to treat a variety of neurological conditions, such as depression, anxiety, epilepsy, and Parkinson's disease. CNS drugs are typically prescribed by neurologists and psychiatrists, and are often used in combination with other medications.
Some companies in the Namenda market include Allergan, Lundbeck, and Otsuka Pharmaceuticals. Show Less Read more
